OBJECTIVE: HIV-associated nephropathy (HIVAN) is the most common cause of end-stage renal disease in persons with HIV/AIDS and is characterized by focal glomerulosclerosis and dysregulated renal tubular epithelial cell (RTEC) proliferation and apoptosis. HIV-1 viral protein r (Vpr) has been implicated in HIV-induced RTEC apoptosis but the mechanisms of Vpr-induced RTEC apoptosis are unknown. The aim of this study was therefore to determine the mechanisms of Vpr-induced apoptosis in RTEC. METHODS: Apoptosis and caspase activation were analyzed in human RTEC (HK2) after transduction with Vpr-expressing and control lentiviral vectors. Bax and BID were inhibited with lentiviral shRNA, and ERK activation was blocked with the MEK1,2 inhibitor, U0126. RESULTS: Vpr induced apoptosis as indicated by caspase 3/7 activation, PARP-1 cleavage and mitochondrial injury. Vpr activated both caspases-8 and 9. Inhibition of Bax reduced Vpr-induced apoptosis, as reported in other cell types. Additionally, Vpr-induced cleavage of BID to tBID and suppression of BID expression prevented Vpr-induced apoptosis. Since sustained ERK activation can activate caspase-8 in some cell types, we studied the role of ERK in Vpr-induced caspase-8 activation. Vpr induced sustained ERK activation in HK2 cells and incubation with U0126 reduced Vpr-induced caspase-8 activation, BID cleavage and apoptosis. We detected phosphorylated ERK in RTEC in HIVAN biopsy specimens by immunohistochemistry. CONCLUSIONS: These studies delineate a novel pathway of Vpr-induced apoptosis in RTEC, which is mediated by sustained ERK activation, resulting in caspase 8-mediated cleavage of BID to tBID, thereby facilitating Bax-mediated mitochondrial injury and apoptosis.
OBJECTIVE: HIV-associated nephropathy (HIVAN) is the most common cause of end-stage renal disease in persons with HIV/AIDS and is characterized by focal glomerulosclerosis and dysregulated renal tubular epithelial cell (RTEC) proliferation and apoptosis. HIV-1 viral protein r (Vpr) has been implicated in HIV-induced RTEC apoptosis but the mechanisms of Vpr-induced RTEC apoptosis are unknown. The aim of this study was therefore to determine the mechanisms of Vpr-induced apoptosis in RTEC. METHODS: Apoptosis and caspase activation were analyzed in human RTEC (HK2) after transduction with Vpr-expressing and control lentiviral vectors. Bax and BID were inhibited with lentiviral shRNA, and ERK activation was blocked with the MEK1,2 inhibitor, U0126. RESULTS:Vpr induced apoptosis as indicated by caspase 3/7 activation, PARP-1 cleavage and mitochondrial injury. Vpr activated both caspases-8 and 9. Inhibition of Bax reduced Vpr-induced apoptosis, as reported in other cell types. Additionally, Vpr-induced cleavage of BID to tBID and suppression of BID expression prevented Vpr-induced apoptosis. Since sustained ERK activation can activate caspase-8 in some cell types, we studied the role of ERK in Vpr-induced caspase-8 activation. Vpr induced sustained ERK activation in HK2 cells and incubation with U0126 reduced Vpr-induced caspase-8 activation, BID cleavage and apoptosis. We detected phosphorylated ERK in RTEC in HIVAN biopsy specimens by immunohistochemistry. CONCLUSIONS: These studies delineate a novel pathway of Vpr-induced apoptosis in RTEC, which is mediated by sustained ERK activation, resulting in caspase 8-mediated cleavage of BID to tBID, thereby facilitating Bax-mediated mitochondrial injury and apoptosis.
Authors: J L Andersen; E S Zimmerman; J L DeHart; S Murala; O Ardon; J Blackett; J Chen; V Planelles Journal: Cell Death Differ Date: 2005-04 Impact factor: 15.828
Authors: K Muthumani; A Y Choo; A Premkumar; D S Hwang; K P Thieu; B M Desai; D B Weiner Journal: Cell Death Differ Date: 2005-08 Impact factor: 15.828
Authors: R K Ravi; E Weber; M McMahon; J R Williams; S Baylin; A Mal; M L Harter; L E Dillehay; P P Claudio; A Giordano; B D Nelkin; M Mabry Journal: J Clin Invest Date: 1998-01-01 Impact factor: 14.808
Authors: Michael J Ross; Matthew S Wosnitzer; Michael D Ross; Benedetta Granelli; G Luca Gusella; Mohammad Husain; Lewis Kaufman; Matthew Vasievich; Vivette D D'Agati; Patricia D Wilson; Mary E Klotman; Paul E Klotman Journal: J Am Soc Nephrol Date: 2006-02-22 Impact factor: 10.121
Authors: Guangtao Zhang; Ruijie Liu; Yifei Zhong; Alexander N Plotnikov; Weijia Zhang; Lei Zeng; Elena Rusinova; Guillermo Gerona-Nevarro; Natasha Moshkina; Jennifer Joshua; Peter Y Chuang; Michael Ohlmeyer; John Cijiang He; Ming-Ming Zhou Journal: J Biol Chem Date: 2012-05-29 Impact factor: 5.157
Authors: Ferdinand Maingat; Brendan Halloran; Shaona Acharjee; Guido van Marle; Deirdre Church; M John Gill; Richard R E Uwiera; Eric A Cohen; Jon Meddings; Karen Madsen; Christopher Power Journal: FASEB J Date: 2011-03-22 Impact factor: 5.191
Authors: Lara Manganaro; Elisa de Castro; Ana M Maestre; Kevin Olivieri; Adolfo García-Sastre; Ana Fernandez-Sesma; Viviana Simon Journal: J Virol Date: 2015-07-15 Impact factor: 5.103
Authors: Anqun Chen; Jin Xu; Han Lai; Vivette D D'Agati; Tian-Jun Guan; Shawn Badal; John Liles; John C He; Kyung Lee Journal: Nephrol Dial Transplant Date: 2021-02-20 Impact factor: 5.992
Authors: Adriana Bora; Ceereena Ubaida Mohien; Raghothama Chaerkady; Linda Chang; Richard Moxley; Ned Sacktor; Norman Haughey; Justin C McArthur; Robert Cotter; Avindra Nath; David R Graham Journal: J Neurovirol Date: 2014-07-24 Impact factor: 2.643